258 related articles for article (PubMed ID: 10986435)
1. Neural tube defects and a disturbed folate dependent homocysteine metabolism.
van der Put NM; Blom HJ
Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):57-61. PubMed ID: 10986435
[TBL] [Abstract][Full Text] [Related]
2. Folate, homocysteine and neural tube defects: an overview.
van der Put NM; van Straaten HW; Trijbels FJ; Blom HJ
Exp Biol Med (Maywood); 2001 Apr; 226(4):243-70. PubMed ID: 11368417
[TBL] [Abstract][Full Text] [Related]
3. Genetic basis of neural tube defects. II. Genes correlated with folate and methionine metabolism.
Gos M; Szpecht-Potocka A
J Appl Genet; 2002; 43(4):511-24. PubMed ID: 12441636
[TBL] [Abstract][Full Text] [Related]
4. Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population.
Richter B; Stegmann K; Röper B; Böddeker I; Ngo ET; Koch MC
J Hum Genet; 2001; 46(3):105-9. PubMed ID: 11310576
[TBL] [Abstract][Full Text] [Related]
5. Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c --> t methylenetetrahydrofolate reductase and 2756a --> g methionine synthase genotypes.
Lucock M; Daskalakis I; Briggs D; Yates Z; Levene M
Mol Genet Metab; 2000 May; 70(1):27-44. PubMed ID: 10833329
[TBL] [Abstract][Full Text] [Related]
6. C677T polymorphism of the methylenetetrahydrofolate reductase gene does not affect folic acid, vitamin B12, and homocysteine serum levels in Turkish children with neural tube defects.
Erdogan MO; Yildiz SH; Solak M; Eser O; Cosar E; Eser B; Koken R; Buyukbas S
Genet Mol Res; 2010 Jun; 9(2):1197-203. PubMed ID: 20589617
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects.
Christensen B; Arbour L; Tran P; Leclerc D; Sabbaghian N; Platt R; Gilfix BM; Rosenblatt DS; Gravel RA; Forbes P; Rozen R
Am J Med Genet; 1999 May; 84(2):151-7. PubMed ID: 10323741
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine, folate enzymes and neural tube defects.
Molloy AM; Weir DG; Scott JM
Haematologica; 1999 Jun; 84 Suppl EHA-4():53-6. PubMed ID: 10907468
[No Abstract] [Full Text] [Related]
9. Polymorphisms in genes involved in folate metabolism as risk factors for NTDs.
De Marco P; Calevo MG; Moroni A; Arata L; Merello E; Cama A; Finnell RH; Andreussi L; Capra V
Eur J Pediatr Surg; 2001 Dec; 11 Suppl 1():S14-7. PubMed ID: 11813127
[TBL] [Abstract][Full Text] [Related]
10. [THE DIFFERENTIATED APPROACH TO PREVENTION OF NEURAL TUBE DEFECTS IN CHILDREN].
Kotova N; Maichuk V; Fedorenko O
Georgian Med News; 2018 Jan; (274):52-59. PubMed ID: 29461227
[TBL] [Abstract][Full Text] [Related]
11. Accurate and rapid "multiplex heteroduplexing" method for genotyping key enzymes involved in folate/homocysteine metabolism.
Barbaux S; Kluijtmans LA; Whitehead AS
Clin Chem; 2000 Jul; 46(7):907-12. PubMed ID: 10894832
[TBL] [Abstract][Full Text] [Related]
12. [Genetic risk factors of neural tube defects].
Sliwerska E; Szpecht-Potocka A
Med Wieku Rozwoj; 2002; 6(4):349-70. PubMed ID: 12810987
[TBL] [Abstract][Full Text] [Related]
13. Folate levels and N(5),N(10)-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case-control study.
Martínez de Villarreal LE; Delgado-Enciso I; Valdéz-Leal R; Ortíz-López R; Rojas-Martínez A; Limón-Benavides C; Sánchez-Peña MA; Ancer-Rodríguez J; Barrera-Saldaña HA; Villarreal-Pérez JZ
Arch Med Res; 2001; 32(4):277-82. PubMed ID: 11440783
[TBL] [Abstract][Full Text] [Related]
14. Prevention of neural tube defects: vitamins, enzymes and genes.
Copp AJ
Curr Opin Neurol; 1998 Apr; 11(2):97-102. PubMed ID: 9551287
[TBL] [Abstract][Full Text] [Related]
15. The curly-tail (ct) mouse, an animal model of neural tube defects, displays altered homocysteine metabolism without folate responsiveness or a defect in Mthfr.
Tran P; Hiou-Tim F; Frosst P; Lussier-Cacan S; Bagley P; Selhub J; Bottiglieri T; Rozen R
Mol Genet Metab; 2002 Aug; 76(4):297-304. PubMed ID: 12208134
[TBL] [Abstract][Full Text] [Related]
16. Does prenatal screening for 5,10-methylenetetrahydrofolate reductase (MTHFR) mutations in high-risk neural tube defect pregnancies make sense?
Finnell RH; Shaw GM; Lammer EJ; Volcik KA
Genet Test; 2002; 6(1):47-52. PubMed ID: 12180076
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in genes of folate metabolism and neural-tube defect risk.
van der Linden IJ; Afman LA; Heil SG; Blom HJ
Proc Nutr Soc; 2006 May; 65(2):204-15. PubMed ID: 16672082
[TBL] [Abstract][Full Text] [Related]
18. Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect.
Al-Gazali LI; Padmanabhan R; Melnyk S; Yi P; Pogribny IP; Pogribna M; Bakir M; Hamid ZA; Abdulrazzaq Y; Dawodu A; James SJ
Am J Med Genet; 2001 Oct; 103(2):128-32. PubMed ID: 11568918
[TBL] [Abstract][Full Text] [Related]
19. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida.
Wilson A; Platt R; Wu Q; Leclerc D; Christensen B; Yang H; Gravel RA; Rozen R
Mol Genet Metab; 1999 Aug; 67(4):317-23. PubMed ID: 10444342
[TBL] [Abstract][Full Text] [Related]
20. How folate fights disease.
Nat Struct Biol; 1999 Apr; 6(4):293-4. PubMed ID: 10201387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
